OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cross-Talk Between m6A- and m5C-Related lncRNAs to Construct a Novel Signature and Predict the Immune Landscape of Colorectal Cancer Patients
Wei Song, Jun Ren, Rensheng Xiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Wei Song, Jun Ren, Rensheng Xiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Showing 16 citing articles:
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 8
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 8
Dynamic RNA methylation modifications and their regulatory role in mammalian development and diseases
Wenlan Yang, Yongliang Zhao, Yun‐Gui Yang
Science China Life Sciences (2024)
Closed Access | Times Cited: 6
Wenlan Yang, Yongliang Zhao, Yun‐Gui Yang
Science China Life Sciences (2024)
Closed Access | Times Cited: 6
Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma
Lin Qi, Wenchao Zhang, Xiaolei Ren, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Lin Qi, Wenchao Zhang, Xiaolei Ren, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma
Jianlin Wang, Huiwen Ren, Chao Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Jianlin Wang, Huiwen Ren, Chao Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients
Jinsong Liu, Min Dou, Xiuling Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11995-12012
Open Access | Times Cited: 7
Jinsong Liu, Min Dou, Xiuling Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11995-12012
Open Access | Times Cited: 7
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells
正則 兜, Xiao-Ting Ma, Mei-Na Piao, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 3106-3125
Open Access | Times Cited: 2
正則 兜, Xiao-Ting Ma, Mei-Na Piao, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 3106-3125
Open Access | Times Cited: 2
RNA Modifications Meet Tumors
Zhiyuan Yang, Siyu Zhang, Tian Xia, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3223-3243
Open Access | Times Cited: 11
Zhiyuan Yang, Siyu Zhang, Tian Xia, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3223-3243
Open Access | Times Cited: 11
Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung Adenocarcinoma
Shuangshuang Mao, Zuhua Chen, Yingying Wu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 10
Shuangshuang Mao, Zuhua Chen, Yingying Wu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 10
Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer
Hongda Pan, Jingxin Pan, Jianghong Wu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Hongda Pan, Jingxin Pan, Jianghong Wu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
m6A‐ and m5C‐ modified lncRNAs orchestrate the prognosis in cutaneous melanoma and m6A‐ modified LINC00893 regulates cutaneous melanoma cell metastasis
Haoze Shi, Cui‐Cui Tian, M. Wu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 1
Haoze Shi, Cui‐Cui Tian, M. Wu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 1
Integrated analysis of N6-methyladenosine- and 5-methylcytosine-related long non-coding RNAs for predicting prognosis in cervical cancer
Jie Gao, Xiuling Zhang, Anqi Xu, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 1
Jie Gao, Xiuling Zhang, Anqi Xu, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 1
Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer
Zhuangzhuang Zheng, Chenbin Bian, Huanhuan Wang, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14, pp. 175883592211383-175883592211383
Open Access | Times Cited: 7
Zhuangzhuang Zheng, Chenbin Bian, Huanhuan Wang, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14, pp. 175883592211383-175883592211383
Open Access | Times Cited: 7
Cancer-associated fibroblasts-derived lncRNA signature as a putative biomarker in breast cancer
Zan Li, Junyi Yu, Chunliu Lv, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Zan Li, Junyi Yu, Chunliu Lv, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Combination of multiple omics techniques for a personalized therapy or treatment selection
Chiara Massa, Barbara Seliger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Chiara Massa, Barbara Seliger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Identification of a novel prognostic signature correlated with epithelial‐mesenchymal transition, N6 ‐methyladenosine modification, and immune infiltration in colorectal cancer
Xiao Qu, Honghong Tan, Jingxian Mao, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 5926-5938
Open Access | Times Cited: 5
Xiao Qu, Honghong Tan, Jingxian Mao, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 5926-5938
Open Access | Times Cited: 5
Integrative Analysis and Experimental Validation of Competing Endogenous RNAs in Obstructive Sleep Apnea
Niannian Li, Yaxin Zhu, Feng Liu, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 639-639
Open Access | Times Cited: 1
Niannian Li, Yaxin Zhu, Feng Liu, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 639-639
Open Access | Times Cited: 1
